Earnings Labs
Galectin Therapeutics Inc. logo

Galectin Therapeutics Inc. (GALT) Earnings

NASDAQ·Healthcare·Biotechnology

$2.34

-1.48%

Mkt Cap $215.98M

Next Earnings

In 22 days

Thu, May 21, 2026

EPS Estimate

-$0.06

1 analysts

Revenue Estimate

$0

Last quarter: beat by +20.00% on EPS.

GALT reports 2026-05-21 earnings on Thursday, May 21, 2026 (22 days from today). Consensus estimates are EPS -$0.06 and revenue $0.

View GALT earnings dates & history

EPS — Estimate vs Actual

Mkt Cap

$215.98M

P/E

Fwd P/E

P/S

Rev TTM

EPS TTM

-$0.48